Subsequent Events |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subsequent Events | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subsequent Events | Note 17. Subsequent EventsUnregistered sales of equity securities In connection with the Company’s continuous private offering, on July 1, 2026, the Company sold an aggregate of 1,280,957 of its common shares at the most recently determined net asset value per share for aggregate consideration of approximately $26,416. The offer and sale of the common shares was exempt from the registration provisions of the Securities Act by virtue of Section 4(a)(2) and Rule 506 of Regulation D promulgated thereunder. The following table details the shares sold:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||